Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025: Annex 1: Research proposal: Selected References

Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025
(1997; 175 pages)

Table of Contents

Executive summary
I. Introduction
II. Background on the research project
	1. Research questions and objectives of the study
	2. Study approach and research tools
	3. Project past activities
III. Second workshop
	1. Aim and objectives
	2. Participants
	3. Method of work and proceedings
IV. Preliminary findings
	1. The methods: What has been learnt?
		1.1 Methods in context: How did the country teams use the methods?
		1.2 Methods in question: What were the main problems encountered and how to solve them?
		1.3 Relevance of the methods
	2. National drug policies: what has been learnt?
		2.1 Preliminary findings based on NDP indicators
		2.2 Preliminary interpretations based on NDP indicators
		2.3 Preliminary findings based on the political mapping
	3. Cross national analysis: What can be learnt at this stage?
		3.1 Relevance of the methods for cross national comparison
		3.2 Strengths and weaknesses of NDP from a cross national perspective
		3.3 Tentative explanations for cross national variations
	4. Broader capacity building
V. Conclusions of the workshop and follow-up plans
	1. Main outcomes
	2. Next steps
Annex 1: Research proposal
	I. Introduction
	II. The Problem
	III. Research Question and Objectives of Proposed Study
	IV. Study Approach
	V. Anticipated Outcomes
	VI. Methods
	VII. Time Line and Resources
	Selected References
Annex 2: List of participants
Annex 3: Agenda
Annex 4: Questionnaire on NDP performance assessment
Annex 5: Achievements of the national drug policies in the 12 countries
	Bulgaria
	Chad
	Colombia
	Guinea
	India
	Mali
	Philippines
	Sri Lanka
	Thailand
	Viet Nam
	Zambia
	Zimbabwe
Annex 6: Consolidated tables
Other documents in the DAP Research Series

Selected References

London School of Hygiene and Tropical Medicine, Royal Tropical Institute of Amsterdam. An Evaluation of WHO'S Action Program on Essential Drugs. 1989.

Brudon-Jakobowicz P, Rainhorn JD, Reich MR. Indicators for Monitoring National Drug Policies. Geneva: WHO, May 1994.

Chowdhury Z. The Bangladesh Experience. Paper presented at the Dag Hammarskjöld Foundation and Ministry of Health, the Philippines seminar 'The Role of National Drug Policies in Social Transformation - A Challenge for the Media', 21-23 February, 1992.

Finer D, Tomson G, eds. Essential Drug Information - The Story of a Work shop. Stockholm: IHCAR, Karolinska Institutet, 1992, in press.

Geest Svd, Whyte SR, eds. The Context of Medicines in Developing Countries: Studies in Pharmaceutical Anthropology. Dordrecht: Kluwer Academic Publishers, 1988.

Goonaratne C. Pharmaceutical Policies for Developing Countries. 2nd Senaka Bibile Oration Paper. Sri Lanka, 1989.

Govindaraj, R. Pharmaceuticals and the Formulation, Implementation, and Evaluation of Drug Policies in Developing Countries. Background Paper for Karolinska-Harvard-WHO Project on Comparative Analysis of National Drug Policies. May, 1994

Hamrell S, Nordberg O, eds. Another development in pharmaceuticals. Development Dialogue (Dag Hammarskjöld Foundation, Uppsala), 1985:2.

Kanji N, Hardon A, Harnmeijer JW, et al. Drugs Policy in Developing Countries. London: Zed Books, 1992.

Kanji N, Munishi G, Sterky G. Essential drugs - Program and policy, Tanzania: Country study. Stockholm: SIDA, 1989.

Kiatying-Angsulee N, Paphassarang C, Tomson G, Wibvulpolprasert S. Towards a National Drug Policy. Review mission of the essential drug sector in Lao PDR. Stockholm: SIDA, 1992.

Kirp DL, Bayer R. eds. AIDS in the Industrialized Countries: Passions, Politics, and Policies. New Brunswick, NJ: Rutgers University Press, 1992.

Montgomery JD, Lasswell HD, Migdal JS, eds. Patterns of Policy: Comparative and Longitudinal Studies of Population Events. N.Brunswick, NJ. Transaction Books, 1979. Rainhorn JD, Brudon-Jakobowicz P, Reich MR. Priorities for Pharmaceutical Policies in Developing Countries: Results of a Delphi Survey. Bulletin of the World Health Organization, 1994.72(2).

Reich MR. Essential drugs: Economics and polities in international health. Health Policy 1987; 8:39-57.

Reich MR. Bangladesh pharmaceutical policy and politics. Health Policy and Planning, in press.

Reich MR. Approaches to comparative health policy. Quaderni di Ricerca 1988; 1-34.

Reich MR. Political Mapping for Health Policy. Boston: Harvard School of Public Health, March 1993.

Report for the Biennium 1990-1991. World Health Organization DAP/MAC(4)/92.4. Geneva: WHO, 1992: 19-22.

Robles A, Mangahas M, Coronel SS, Gamalinda E, eds. Prescription for Change: National Drug Policies, Social Transformation and the Media. Manila: Philippine Center for Investigative Journalism, Dag Hammarskjolk Foundation, 1992.

Sterky G, Tomson, G, Sachs L, eds. Medicines and Society - A Challenge in Health Development. Stockholm: IHCAR, Karolinska Institutet, 1988.

Tomson G. Drug Utilization Studies in Sri Lanka - Towards an Understanding of medicines in society. Stockholm: IHCAR, Karolinska Institutet, 1990.

WHO. Guidelines for national drug policies. Geneva: World Health Organization, 1988.

WHO. The selection of essential drugs. Geneva: World Health Organization/TRS 615, 1977.

World Health Organization. The World Drug Situation. Geneva: WHO, 1988.